Dan Hicklin

2.3k citations
21 papers · 1.9k · 1 hit paper · h-index 10

Impact in

Papers in

    • Angiogenesis and VEGF in Cancer 8
    • Colorectal Cancer Treatments and Studies 2
    • HER2/EGFR in Cancer Research 2

Dan Hicklin

20 papers receiving 1.8k citations

Dan Hicklin's Hit Papers

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. 1999 · 557 citations
5570+9+18Years since publication100200300400500

Peers

Dan Hicklin
Comparison fields: 5 of 84
  • Cancer Research 423
  • Immunology and Allergy 120
  • Molecular Biology 1.3k
  • Hematology 212
  • Cell Biology 295
Replace Ann Bouché with:
Ann Bouché Belgium
Carlie de Vries Netherlands
Domenico Maglione Italy
Hela Gitay-Goren Israel
Lea T. Berleau United States
Shravan K. Chintala United States
Fabienne Baffert Switzerland
Bernhard Barleon Germany
Athina Lymboussaki Finland
Sina Koch Germany
Dan Hicklin relative to Ann Bouché Belgium Ann Bouché's profile →
Citations per field
00.5×1.7×
Ann Bouché · 1×
Citations per year

Countries citing papers authored by Dan Hicklin

Since Specialization
Citations

This map shows the geographic impact of Dan Hicklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Hicklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Hicklin more than expected).

Fields of papers citing papers by Dan Hicklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Hicklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Hicklin. The network helps show where Dan Hicklin may publish in the future.

Co-authors

The 25 scholars most cited alongside Dan Hicklin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dan Hicklin Line = papers co-authored together Dan Hicklin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Hit paper breakdown →
1999557
2 2002387
3 2002301
4 1994167
5 2006162
6 2003155
7 200747
8 200237
9 199617
10
Identification and characterization of a fully human antibody directed against epidermal growth factor receptor for cancer therapy
200414
11 20046
12 20214
13 20054
14 20213
15 20063
16 20053
17
SCH 727965, a novel cyclin-dependent kinase inhibitor, has potent anti-tumor acitivity in a wide-spectrum of human tumor xenograft models
20081
18 20041
19 20061
20 20041

About Dan Hicklin

Dan Hicklin is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (8 papers), Zebrafish Biomedical Research Applications (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Axon Guidance and Neuronal Signaling (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Acute Myeloid Leukemia Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Cancer Research (423 citations), Immunology and Allergy (120 citations), Molecular Biology (1.3k citations), Hematology (212 citations) and Cell Biology (295 citations). Dan Hicklin has collaborated with scholars based in United States, Germany and Israel. Frequent co-authors include Luc de Witte, Yiwen Li, Peter Böhlen, Bronislaw Pytowski, Marie Prewett, Andrea T. Hooper, JC Huber, Ángel Santiago, James C. Overholser and William O’Connor. Their work appears in journals such as Cancer Research, Journal of Clinical Investigation, Blood, Molecular Cancer Therapeutics and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact